Literature DB >> 18097698

Patient access to rheumatoid arthritis treatments.

Bengt Jönsson, Gisela Kobelt, Josef Smolen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18097698     DOI： 10.1007/s10198-007-0085-y

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  2 in total

1.  Induction of response with etanercept-methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study.

Authors:  Karel Pavelka; Zoltan Szekanecz; Nemanja Damjanov; Maria Majdan; Evgeny Nasonov; Vadim Mazurov; Tibor Fabo; Eustratios Bananis; Heather Jones; Annette Szumski; Boxiong Tang; Sameer Kotak; Andrew S Koenig; Radu Vasilescu
Journal:  Clin Rheumatol       Date:  2013-05-11       Impact factor: 2.980

2.  Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries.

Authors:  Ewa Orlewska; Ioan Ancuta; Branimir Anic; Catalin Codrenau; Nemanja Damjanov; Predrag Djukic; Ruxandra Ionescu; Lubomir Marinchev; Evgeny L Nasonov; Tonu Peets; Sonja Praprotnik; Rasho Rashkov; Jana Skoupa; Witold Tlustochowicz; Malgorzata Tlustochowicz; Matija Tomsic; Tiina Veldi; Jelena Vojinovic; Piotr Wiland
Journal:  Med Sci Monit       Date:  2011-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.